Literature DB >> 17940012

Bringing the genetics of macular degeneration into focus.

Jonathan L Haines1, Kylee M Spencer, Margaret A Pericak-Vance.   

Abstract

Mesh：

Year:  2007        PMID： 17940012      PMCID： PMC2040461          DOI： 10.1073/pnas.0708151104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  25 in total

1.  A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors.

Authors:  Debra A Schaumberg; Susan E Hankinson; Qun Guo; Eric Rimm; David J Hunter
Journal:  Arch Ophthalmol       Date:  2007-01

2.  HTRA1 promoter polymorphism in wet age-related macular degeneration.

Authors:  Andrew Dewan; Mugen Liu; Stephen Hartman; Samuel Shao-Min Zhang; David T L Liu; Connie Zhao; Pancy O S Tam; Wai Man Chan; Dennis S C Lam; Michael Snyder; Colin Barnstable; Chi Pui Pang; Josephine Hoh
Journal:  Science       Date:  2006-10-19       Impact factor: 47.728

3.  A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.

Authors:  Zhenglin Yang; Nicola J Camp; Hui Sun; Zongzhong Tong; Daniel Gibbs; D Joshua Cameron; Haoyu Chen; Yu Zhao; Erik Pearson; Xi Li; Jeremy Chien; Andrew Dewan; Jennifer Harmon; Paul S Bernstein; Viji Shridhar; Norman A Zabriskie; Josephine Hoh; Kimberly Howes; Kang Zhang
Journal:  Science       Date:  2006-10-19       Impact factor: 47.728

4.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.

Authors:  Anne E Hughes; Nick Orr; Hossein Esfandiary; Martha Diaz-Torres; Timothy Goodship; Usha Chakravarthy
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

5.  Risk factors for age-related macular degeneration: Pooled findings from three continents.

Authors:  W Smith; J Assink; R Klein; P Mitchell; C C Klaver; B E Klein; A Hofman; S Jensen; J J Wang; P T de Jong
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

Review 6.  Oxidative damage and age-related macular degeneration.

Authors:  B S Winkler; M E Boulton; J D Gottsch; P Sternberg
Journal:  Mol Vis       Date:  1999-11-03       Impact factor: 2.367

7.  Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.

Authors:  Gregory S Hageman; Lisa S Hancox; Andrew J Taiber; Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Monte J Radeke; David Kavanagh; Anna Richards; John Atkinson; Seppo Meri; Julie Bergeron; Jana Zernant; Joanna Merriam; Bert Gold; Rando Allikmets; Michael Dean
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

8.  Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.

Authors:  Kylee L Spencer; Michael A Hauser; Lana M Olson; Silke Schmidt; William K Scott; Paul Gallins; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Hum Mol Genet       Date:  2007-06-18       Impact factor: 6.150

9.  A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.

Authors:  Atsuhiro Kanda; Wei Chen; Mohammad Othman; Kari E H Branham; Matthew Brooks; Ritu Khanna; Shirley He; Robert Lyons; Gonçalo R Abecasis; Anand Swaroop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-20       Impact factor: 11.205

10.  Complement C3 variant and the risk of age-related macular degeneration.

Authors:  John R W Yates; Tiina Sepp; Baljinder K Matharu; Jane C Khan; Deborah A Thurlby; Humma Shahid; David G Clayton; Caroline Hayward; Joanne Morgan; Alan F Wright; Ana Maria Armbrecht; Baljean Dhillon; Ian J Deary; Elizabeth Redmond; Alan C Bird; Anthony T Moore
Journal:  N Engl J Med       Date:  2007-07-18       Impact factor: 91.245
View more
  7 in total

1.  Evaluation of potential therapies for a mouse model of human age-related macular degeneration caused by delayed all-trans-retinal clearance.

Authors:  Tadao Maeda; Akiko Maeda; Melissa Matosky; Kiichiro Okano; Satsumi Roos; Johnny Tang; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-03       Impact factor: 4.799

Review 2.  Complement inhibitors for age-related macular degeneration.

Authors:  Michael A Williams; Gareth J McKay; Usha Chakravarthy
Journal:  Cochrane Database Syst Rev       Date:  2014-01-15

Review 3.  Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration.

Authors:  Robert S Molday; Kang Zhang
Journal:  Prog Lipid Res       Date:  2010-07-13       Impact factor: 16.195

Review 4.  Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration.

Authors:  Anand Swaroop; Emily Y Chew; Catherine Bowes Rickman; Gonçalo R Abecasis
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

5.  Retinopathy in mice induced by disrupted all-trans-retinal clearance.

Authors:  Akiko Maeda; Tadao Maeda; Marcin Golczak; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

6.  Translational research in retinology.

Authors:  Rubens Camargo Siqueira; Rodrigo Jorge
Journal:  Clin Ophthalmol       Date:  2011-10-14

7.  IKK2 inhibition attenuates laser-induced choroidal neovascularization.

Authors:  Huayi Lu; Qingxian Lu; Subhash Gaddipati; Ramesh Babu Kasetti; Wei Wang; Manolis Pasparakis; Henry J Kaplan; Qiutang Li
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.